InMed Prognostics offers an AI and machine learning (ML)-based MRI tool to neuro radiologists, neuro physicians and psychiatrists.
InMed Prognostics offers an AI and machine learning (ML)-based MRI tool to neuroradiologists, neuro physicians, and psychiatrists. Its flagship product Neuroshield integrates MRI images, clinical reports, and psychological assessments to produce automated, quantified reports to support the physician’s clinical impression for various neurological disorders.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 16, 2020 | Seed | — | 1 | India EdisonTM Accelerator | — | Detail |
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jan 28, 2019
CreditVidya
|
Series B | $3M | Credit | — |
Investor Name | Lead Investor | Funding Round |
---|---|---|
India EdisonTM Accelerator | Yes | Seed |